| Guidelines for the management of hemophilia | Haemophilia | 2013 | 1.2K |
| Epidemiology and risk factors of urothelial bladder cancer | European Urology | 2013 | 1.2K |
| Definitions and diagnosis of pulmonary hypertension | Journal of the American College of Cardiology | 2013 | 1.2K |
| The Oslo definitions for coeliac disease and related terms | Gut | 2013 | 992 |
| Minimum requirements for the diagnosis of psychogenic nonepileptic seizures: a staged approach: a report from the International League Against Epilepsy Nonepileptic Seizures Task Force | Epilepsia | 2013 | 420 |
| EUCAST expert rules in antimicrobial susceptibility testing | Clinical Microbiology and Infection | 2013 | 386 |
| Non-Celiac Gluten sensitivity: the new frontier of gluten related disorders | Nutrients | 2013 | 344 |
| Efficacy and tolerability of mirabegron, a β(3)-adrenoceptor agonist, in patients with overactive bladder: results from a randomised European-Australian phase 3 trial | European Urology | 2013 | 299 |
| Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes | European Journal of Endocrinology | 2013 | 259 |
| Randomized double-blind, active-controlled phase 3 study to assess 12-month safety and efficacy of mirabegron, a β(3)-adrenoceptor agonist, in overactive bladder | European Urology | 2013 | 246 |
| OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial | European Urology | 2013 | 244 |
| Oral treprostinil for the treatment of pulmonary arterial hypertension in patients receiving background endothelin receptor antagonist and phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C2 study): a randomized controlled trial | Chest | 2013 | 224 |
| Guidelines for the management of vitiligo: the European Dermatology Forum consensus | British Journal of Dermatology | 2013 | 218 |
| Mechanisms and management of diabetic painful distal symmetrical polyneuropathy | Diabetes Care | 2013 | 186 |
| Management of psychogenic nonepileptic seizures | Epilepsia | 2013 | 181 |
| Duloxetine and pregabalin: high-dose monotherapy or their combination? The "COMBO-DN study"--a multinational, randomized, double-blind, parallel-group study in patients with diabetic peripheral neuropathic pain | Pain | 2013 | 172 |
| Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy | Epilepsia | 2013 | 162 |
| Guideline on the management of bleeding in patients on antithrombotic agents | British Journal of Haematology | 2013 | 155 |
| The multifaceted role of the microenvironment in liver metastasis: biology and clinical implications | Cancer Research | 2013 | 147 |
| Preanalytical quality improvement: in quality we trust | Clinical Chemistry and Laboratory Medicine | 2013 | 124 |
| Pulmonary hypertension in COPD: results from the ASPIRE registry | European Respiratory Journal | 2013 | 117 |
| A comparison of intrauterine balloon, intrauterine contraceptive device and hyaluronic acid gel in the prevention of adhesion reformation following hysteroscopic surgery for Asherman syndrome: a cohort study | European Journal of Obstetrics, Gynecology and Reproductive Biology | 2013 | 114 |
| A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR) | International Urogynecology Journal | 2013 | 109 |
| Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis | International Journal of Laboratory Hematology | 2013 | 109 |
| Prevalence of irritable bowel syndrome-type symptoms in patients with celiac disease: a meta-analysis | Clinical Gastroenterology and Hepatology | 2013 | 108 |
